FNArena Windows
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
Latest Stories
Sigma Healthcare’s transformational merger with Chemist Warehouse provides for strong growth in sales, earnings, synergies and store-count in FY26 and beyond
Aug 29 2025
New research on Sigma Healthcare highlights management’s conservative cost synergy target, as well as potential market share gains and operating leverage
Jun 19 2025
| ASX CODE | LAST PRICE | % MOVE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET | UPSIDE/DOWNSIDE |
|---|---|---|---|---|---|---|---|
| CLV | $0.55 | 0.00% | $0.60 | $0.34 | 13.8 |
$0.68 |
|
| EBO | $29.77 |
|
$38.23 | $28.01 | 20.6 |
$34.873 |
|
| EXL | $0.02 | 0.00% | $0.05 | $0.00 |
|
||
| MCP | $0.26 | 0.00% | $0.43 | $0.21 |
|
||
| SIG | $3.14 |
|
$3.32 | $1.25 | 50.3 |
$3.023 |
|
23.6% 
Previous Stories
Sigma Healthcare Promises Higher Margins
Oct 03 2023
While interim results for Sigma Healthcare met expectations, brokers see margin upside from improved operating leverage
Sigma’s Win Not Neccessarily Ebos’ Loss
Jun 14 2023
While Sigma Healthcare is a clear winner in gaining the Chemist Warehouse contract from Ebos, the damage is not that significant for Ebos in broker views
Sigma Healthcare: Brokers Wary
Mar 31 2022
Following FY21 results for Sigma Healthcare brokers see an uncertain outlook for near-term earnings
Health & Wellness Boom On The ASX
Apr 29 2021
The New Criterion’s Tim Boreham highlights some interesting health and wellness stocks to monitor
M&A Now On Sigma Healthcare’s Agenda
Mar 24 2021
Having completed its efficiency drive, Sigma Healthcare is looking to M&A to enable future growth
McPherson’s Expands Into Herbal Health
Nov 04 2020
McPherson’s has expanded into the herbal product segment by acquiring Global Therapeutics and can now build out that business across its pharmacy distribution channel.
Nine Ignored Companies Now Worth A Look
Sep 23 2020
Peter Switzer of the Switzer Report highlights nine stocks that aren’t his top picks, but that analysts believe offer solid upside ahead.
Next Week At A Glance – 14-18 Sep 2020
Sep 11 2020
A brief look at important company events and economic data releases next week
Sigma Farewells API, Heralds New Contract
Dec 17 2019
Sigma Healthcare has adjusted guidance to account for the renewed Chemist Warehouse contract, while Australian Pharmaceutical Industries finally takes its hat out of the merger ring.
Blackmores: Hopes Pinned On Restructuring
Nov 01 2019
Blackmores’ first half profit warning has sent analysts into a scramble to downgrade forecasts, but turnaround potential has been boosted by a shift in strategy.